ClinicalTrials.Veeva

Menu

Triglyceride Rich Lipoproteins and Platelet Activation in Type 2 Diabetes (COMPLETE)

Civil Hospices of Lyon logo

Civil Hospices of Lyon

Status

Completed

Conditions

Type2 Diabetes

Treatments

Other: Chocolate spread based breakfast
Other: butter based breakfast

Study type

Interventional

Funder types

Other

Identifiers

NCT03561571
69HCL18_0326

Details and patient eligibility

About

To investigate in vitro the effect of triglyceride rich lipoproteins (TGRL) obtained in type 2 diabetic women in the fasting state and following a randomized isocaloric lipid rich breakfast on control human platelets

Randomized Comparison of butter versus chocolate spread in 2 groups of 15 patients

Enrollment

32 patients

Sex

Female

Ages

50 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Menopausal women
  • HbA1c ≥6,5 ou ≤10%
  • 27 ≤ BMI ≤40 kg/m2

Exclusion criteria

  • Insulin therapy
  • fibrates or Omega 3 fatty acids supplements
  • Hormonal replacement therapy of menopause
  • Glycemia > 16 mmol/l
  • Alcohol abuse (≥3 Unit/day)
  • Special dietary habits
  • History of bariatric surgery

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

32 participants in 2 patient groups

Butter based breakfast
Active Comparator group
Treatment:
Other: butter based breakfast
Chocolate spread based breakfast
Active Comparator group
Treatment:
Other: Chocolate spread based breakfast

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems